Past use of metformin is associated with increased risk of myelodysplastic syndrome development in diabetes mellitus patients: a cross-sectional study of 54,869 patients.

BMC Pharmacol Toxicol · 2025 · PMC11869568 · PMID 40016854

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

did not reach statistical significancep = 0.058so close (0.05 < p ≤ 0.1)

CHF and dementia did not reach statistical significance (OR = 1.31, 95% CI [0.98–1.71]; p = 0.058, and OR = 0.59, 95% CI [0.28–1.09]; p = 0.123 respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.